corporary

CURLIM

Active
SIREN 985116748 VAT number FR40985116748 LEI 969500GJALMGUAODJ903

Business purpose.

le développement de tout produit innovant en matière médicale, notamment de médicaments, destiné à soigner des patients atteints de maladies neurologiques, en particulier des nerfs périphériques (neuropathies) ; l'étude, la recherche, la mise au point, la fabrication industrielle et la commercialisation de ces dits produits ; l'exploitation et le développement de tous brevets ou licences relatifs à ces produits.

Identity

Legal form
SAS, simplified joint-stock company
Activity
Other research and experimental development on natural sciences and engineering (72.19Z)
Sector
Scientific research and development
Headcount
3 to 5 employees
Created
23 Feb 2024
Share capital
177,798.00 EUR
Establishments
1

Directors

Related companies

Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.

Other companies at the same address

43 other company head offices are registered at this address.

Establishments

Financial strength

Financial score

88 / 100 A

Confidence: low · computed on the financial year ended 31 Dec 2024

Equity to assets (79.1 %)
26.4 out of 30
EBITDA margin
data missing, component not taken into account
Liquidity (847.2 %)
18.6 out of 20
Debt (16.0 %)
12.2 out of 15
Revenue trend
data missing, component not taken into account

formula fin-1.0

Legal score

85 / 100 A

Confidence: high

No insolvency proceedings
40.0 out of 40
Currently trading
20.0 out of 20
Age (2.7 years)
5.5 out of 20
Accounts filed recently
20.0 out of 20

formula leg-1.0

These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated

Revenue and earnings

Detailed accounts for this company are not reproduced here, but its main aggregates are public.

Financial year Revenue Change EBITDA Net income
31 Dec 2024 0 € first year on record -67,309 € -66,252 €

Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.

Explore similar companies

Collective agreements

Agreements declared by the employer in its payroll filings.

  • Convention collective nationale de l'industrie pharmaceutique du 6 avril 1956. Etendue par arrêté du 15 novembre 1956 JORF 14 décembre 1956.

    IDCC 0176 · repealed · 1 establishment · declared in August 2026

Legal notices

  • Filing of accounts 20 May 2026
    Court :
    Greffe du Tribunal des Activités Economiques de limoges
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2025

    BODACC C n 20260094, annonce n 2168 · Proof of publication (PDF)

  • Filing of accounts 13 Jun 2025
    Court :
    Greffe du Tribunal des Activités Economiques de limoges
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2024

    BODACC C n 20250112, annonce n 5979 · Proof of publication (PDF)

  • Amendment 2 Jan 2025
    Court :
    Greffe du Tribunal de Commerce de Limoges
    Amendment :
    modification survenue sur le capital (augmentation)

    BODACC B n 20250001, annonce n 2408 · Proof of publication (PDF)

  • Amendment 31 Jul 2024
    Court :
    Greffe du Tribunal de Commerce de Limoges
    Amendment :
    modification survenue sur le capital (augmentation)

    BODACC B n 20240147, annonce n 274 · Proof of publication (PDF)

  • Amendment 5 Jul 2024
    Court :
    Greffe du Tribunal de Commerce de Limoges
    Amendment :
    modification survenue sur l'administration

    BODACC B n 20240129, annonce n 1904 · Proof of publication (PDF)

  • Amendment 4 Jul 2024
    Court :
    Greffe du Tribunal de Commerce de Limoges
    Amendment :
    modification survenue sur le capital (augmentation)

    BODACC B n 20240128, annonce n 5189 · Proof of publication (PDF)

  • Incorporation 10 Mar 2024
    Court :
    Greffe du Tribunal de Commerce de Limoges

    BODACC A n 20240049, annonce n 621 · Proof of publication (PDF)

Filings and annual accounts as PDF →

Filings and accounts

  • Formality 29 Feb 2024

Change history

  • Change in the register 4 Nov 2026
  • Change in the register 3 Nov 2026
  • Appointed: President de SAS 10 Oct 2026
  • Appointed: President de SAS 10 Oct 2026
  • Appointed: President de SAS 10 Oct 2026
  • Share capital changed from 119,000 € to 139,000 € 2 Oct 2026
  • Share capital changed from 80,000 € to 119,000 € 2 Oct 2026
  • Share capital changed from 177,798 € to 80,000 € 2 Oct 2026
  • Registered office: 1 avenue d'Ester 87069 Limoges 2 Oct 2026
  • Share capital: 177,798 € 2 Oct 2026

Frequently asked questions about CURLIM

What is the SIREN number of CURLIM?
The SIREN number of CURLIM is 985116748. Its intra-community VAT number is FR40985116748.
Where is the head office of CURLIM?
Head office address: 1 AVENUE D'ESTER, 87280 LIMOGES.
When was CURLIM founded?
CURLIM was founded on 23 Feb 2024.
What does CURLIM do?
Its declared main activity is: Other research and experimental development on natural sciences and engineering (NAF code 72.19Z).
Who runs CURLIM?
The officers listed in the register are Franck Georges Henri STURTZ (President de SAS), FRANCK GEORGES HENRI Sturtz (President de SAS), LAURENT MATHIAS EMMANUEL Richebourg (President de SAS).
What is the revenue of CURLIM?
The latest published revenue is 0 €, for the 2024 financial year.
How many employees does CURLIM have?
The declared headcount is 3 to 5 employees. Insee data for 2024.
Is CURLIM subject to insolvency proceedings?
No ongoing insolvency proceedings are published in the BODACC for this company.

In the official registers

Further reading

Show this profile on your website →

Report an error or request removal of this data